Regina Rabinovich has over 25 years of experience in global health across research, public health, and philanthropic sectors, with focus on strategy, global health product development, and the introduction and scale-up of tools and strategies resulting in impact on endemic populations.
In 2013, Dr. Rabinovich became an International Scholar at ISGlobal, where she leads the Malaria Elimination Initiative and acts as a senior advisor for the Malaria Eradication Scientific Alliance (MESA). She is also the ExxonMobil Malaria Scholar in Residence at Harvard University.
Prior to that, Dr. Rabinovich served as Director of the Infectious Diseases division at the Bill & Melinda Gates Foundation from 2003-2012, overseeing the development and implementation of strategies for the prevention, treatment, and control of infectious diseases of particular relevance to malaria, pneumonia, diarrhea, and neglected infectious diseases.
Dr. Rabinovich has served in Chief of the Clinical and Regulatory Affairs Branch at the US National Institute of Allergy and Infectious Diseases (NIAID), focusing on the development and evaluation of vaccines through a network of US clinical research units. She participated in the Children's Vaccine Initiative, a global effort to prevent infectious diseases in children in the developing world.
In 1999, Dr. Rabinovich became director of the PATH Malaria Vaccine Initiative, a project funded by the Bill & Melinda Gates Foundation to advance efforts to develop promising malaria vaccine candidates. She serves on the boards of AERAS, a non-profit biotech focused on development of vaccines for tuberculosis, and the Catholic Medical Mission Board.